Ethological analysis of scopolamine treatment or pretreatment in morphine dependent rats

Physiology and Behavior

Volumn 88, Issue 1-2, 2006, Pages 183-190

  Xiang, Xiao Hui ^a   Wang, Hui Ling ^b   Wu, Wei Ran ^c   Guo, Yuan ^a   Cao, Dong Yuan ^a   Wang, Hui Sheng ^a   Zhao, Yan ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Morphine dependence; Morphine excretion; Morphine withdrawal signs; Scopolamine

Indexed keywords

NALOXONE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; ETHOLOGY; FLUID INTAKE; GENITAL SYSTEM; GROOMING; IRRITABILITY; JUMPING; MALE; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; PTOSIS; RAT; URINARY EXCRETION; URINE VOLUME; WEIGHT REDUCTION; WET DOG SHAKES; WITHDRAWAL SYNDROME; WRITHING TEST;

EID: 33744529570     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2006.03.029     Document Type: Article

References (65)

1. Nestler E.J. Molecular mechanisms of opiate and cocaine addiction. Curr Opin Neurobiol 7 5 (1997) 713-719
2. Nestler E.J. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 25 4 (2004) 210-218
3. Lane-Ladd S.B., Pineda J., Boundy V.A., Pfeuffer T., Krupinski J., Aghajanian G.K., et al. CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17 20 (1997) 7890-7901
4. Nestler E.J. Molecular neurobiology of addiction. Am J Addict 10 3 (2001) 201-217
5. 1 dopamine receptors modulate deltaFosB induction in rat striatum after intermittent morphine administration. J Pharmacol Exp Ther 314 1 (2005) 148-154
6. McClung C.A., Ulery P.G., Perrotti L.I., Zachariou V., Berton O., and Nestler E.J. DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res Mol Brain Res 132 2 (2004) 146-154
7. 2+/calmodulin-dependent protein kinase II alpha during chronic morphine exposure. Neuroscience 123 3 (2004) 769-775
8. Lu L., Zeng S., Liu D., and Ceng X. Inhibition of the amygdala and hippocampal calcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in rats. Neurosci Lett 291 3 (2000) 191-195
9. Wang H.L., Zhao Y., Xiang X.H., Wang H.S., and Wu W.R. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats. Prog Neuro-Psychopharmacol Biol Psychiatry 28 7 (2004) 1079-1087
10. Zhu H., Jenab S., Jones K.L., and Inturrisi C.E. The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal rat. Brain Res Dev Brain Res 142 2 (2003) 209-213
11. Spiga S., Serra G.P., Puddu M.C., Foddai M., and Diana M. Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy. Eur J Neurosci 17 3 (2003) 605-612
12. Harlan R.E., Kailas S.R., Tagoe C.E., and Garcia M.M. Morphine actions in the rat forebrain: role of protein kinase C. Brain Res Bull 62 4 (2004) 285-295
13. Crossland J., and Ahmed K.Z. Brain acetylcholine during morphine withdrawal. Neurochem Res 9 3 (1984) 351-366
14. Domino E.F., and Wilson A.E. Letter: enhanced utilization of brain acetylcholine during morphine withdrawal in the rat. Nature 243 5405 (1973) 285-286
15. Pinsky C., Frederickson R.C., and Vazquez A.J. Morphine withdrawal syndrome responses to cholinergic antagonists and to a partial cholinergic agonist. Nature 242 5392 (1973) 59-60
16. Redmond Jr. D.E., and Krystal J.H. Multiple mechanisms of withdrawal from opioid drugs. Annu Rev Neurosci 7 (1984) 443-478
17. Rada P., Pothos E., Mark G.P., and Hoebel B.G. Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine. Brain Res 561 2 (1991) 354-356
18. Maldonado R., Blendy J.A., Tzavara E., Gass P., Roques B.P., Hanoune J., et al. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273 5275 (1996) 657-659
19. Nye H.E., and Nestler E.J. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol Pharmacol 49 4 (1996) 636-645
20. Trujillo K.A., and Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251 4989 (1991) 85-87
21. Tzschentke T.M., and Schmidt W.J. N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci Lett 193 1 (1995) 37-40
22. Stewart J., de Wit H., and Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev 91 2 (1984) 251-268
23. Yang G.D., Xu K., Luo Q., Zhou W.H., and Wang Z.L. Clinical study of scopolamine detoxification for the treatment of heroin addicts. Natl Med J China 76 2 (1996) 141-144
24. Yang G.D., Zhou W.H., Xu K., Li W.H., Jiang L.F., Zhang J.B., et al. The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts. Natl Med J China 79 9 (1999) 679-682
25. Yang G.D., Zhou W.H., Zhang F.Q., Zhang Y.H., Liu H.F., Zhu B., et al. Experimental study of selective muscarinic receptor antagonists on attenuation of morphine tolerance and dependence in rats. Natl Med J China 77 2 (1997) 130-133
26. Zhou W.H., Zhu B., Chen Q.J., Zhang F.Q., and Yang G.D. Effect of scopolamine on morphine levels in serum and urine in rats. Natl Med J China 75 1 (1995) 5-7
27. Gronier B., and Rasmussen K. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat. Br J Pharmacol 124 3 (1998) 455-464
28. Zhang F.Q., Zhou W.H., Chen Q.J., Zhu B., and Yang G.D. Effects of scopolamine on serotonin in the spinal cord and atria of morphine-dependent rats. Natl Med J China 75 3 (1995) 161-163
29. 2 muscarinic receptors associated with a small increase in intracellular calcium. Pharmacology 55 1 (1997) 10-17
30. Gholami A., Zarrindast M.R., Sahraei H., and Haerri-Rohani A. Nitric oxide within the ventral tegmental area is involved in mediating morphine reward. Eur J Pharmacol 458 1-2 (2003) 119-128
31. Wang Y., Yu Y.Q., Li W.Y., Jiang B., and Xu J.G. Enhanced immunoreactiom of phosphorylated-CREB and the cytoplasmic calcium responses in peripheral lymphocytes from morphine dependent rats. Chin J Neuroimmunol Neurol 9 1 (2002) 49-52
32. Zhou H., Ge X., Wang L.Z., Ma L., and Pei G. Attenuation of morphine tolerance and dependence in scopolamine-treated rats. Neuroreport 10 10 (1999) 2007-2010
33. Liu H.F., Zhang Y.H., Wang Z.L., and Chen Q.J. The quantity-effect of scopolamine in treating morphine dependent rats. Zhejiang Journal of Integrated Traditional Chinese and Western Medicine 4 3 (1994) 30-31
34. Wu L.P., Deng H.C., Zhang D.R., Zhang Z.W., and Zhou C. Clinical observation on acute withdrawal symptoms controlled by scopolamine in heroin addicts. Chin Hosp Pharm J 21 1 (2001) 32-33
35. Buccafusco J.J., Zhang L.C., Shuster L.C., Jonnala R.R., and Gattu M. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats. Brain Res 852 1 (2000) 76-83
36. Delle M., Thoren P., Skarphedinsson J.O., Hoffman P., Carlsson S., and Ricksten S. Differentiated responses of renal and adrenal sympathetic nerve activity to intravenous morphine administration in anesthetized rats. J Pharmacol Exp Ther 253 2 (1990) 655-660
37. Langerman L., Piscoun B., Bansinath M., Shemesh Y., Turndorf H., and Grant G.J. Quantifiable dose-dependent withdrawal after morphine discontinuation in a rat model. Pharmacol Biochem Behav 68 1 (2001) 1-6
38. 2 muscarinic receptor of spinal cord mediated increase of nNOS expression in locus coeruleus during morphine withdrawal. Acta Pharmacol Sin 23 8 (2002) 691-697
39. Valverde O., and Roques B.P. Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in rats. Neurosci Lett 244 1 (1998) 37-40
40. Busquets X., Ventayol P., and Garcia-Sevilla J.A. Naloxone-precipitated withdrawal in morphine-dependent rats increases the expression of alpha 2a-adrenoceptor mRNA in brain. Brain Res Mol Brain Res 45 1 (1997) 154-158
41. Aricioglu-Kartal F., Kayir H., and Tayfun Uzbay I. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats. Life Sci 73 18 (2003) 2363-2371
42. Fdez Espejo E., Cador M., and Stinus L. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score". Psychopharmacology (Berl) 122 2 (1995) 122-130
43. Gellert V.F., and Holtzman S.G. Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J Pharmacol Exp Ther 205 3 (1978) 536-546
44. Torres G., and Horowitz J.M. Drugs of abuse and brain gene expression. Psychosom Med 61 5 (1999) 630-650
45. Goldstein F.J. Adjuncts to opioid therapy. J Am Osteopath Assoc 102 9 Suppl 3 (2002) S15-S21
46. Broseta I., Rodriguez-Arias M., Stinus L., and Minarro J. Ethological analysis of morphine withdrawal with different dependence programs in male mice. Prog Neuro-Psychopharmacol Biol Psychiatry 26 2 (2002) 335-347
47. Bristow L.J., Hogg J.E., and Hutson P.H. Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats. Neuropharmacology 36 2 (1997) 241-250
48. Caille S., Espejo E.F., Reneric J.P., Cador M., Koob G.F., and Stinus L. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J Pharmacol Exp Ther 290 2 (1999) 881-892
49. Jones K.L., Zhu H., Jenab S., Du T., Inturrisi C.E., and Barr G.A. Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959. Neuropsychopharmacology 26 3 (2002) 301-310
50. 2+ channel blocker, on naloxone-increased glutamate levels in the locus coeruleus of opioid-dependent rats. Brain Res 722 1-2 (1996) 212-216
51. Tokuyama S., Wakabayashi H., and Ho I.K. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Eur J Pharmacol 295 2-3 (1996) 123-129
52. Tokuyama S., Zhu H., Oh S., Ho I.K., and Yamamoto T. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids. Neurochem Int 39 2 (2001) 103-109
53. Block M.L., and Fisher A.E. Cholinergic and dopaminergic blocking agents modulate water intake elicited by deprivation, hypovolemia, hypertomicity and isoproterenol. Pharmacol Biochem Behav 3 2 (1975) 251-262
54. Bhargava H.N., and Way E.L. Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists. Eur J Pharmacol 36 1 (1976) 79-88
55. Marshall D.C., and Buccafusco J.J. Spinal cholinergic neurons and the expression of morphine withdrawal symptoms in the rat. J Neurosci 7 3 (1987) 621-628
56. McGinty J.F. Regulation of neurotransmitter interactions in the ventral striatum. Ann N Y Acad Sci 877 (1999) 129-139
57. Wang H.L., Xiang X.H., Guo Y., Wu W.R., Cao D.Y., Wang H.S., et al. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats. Eur J Pharmacol 527 1-3 (2005) 94-104
58. Niu Z.P., and Liu YX. Flos daturae to influence rat's electrostimulus-induced cerebral cortex convulsant threshold and its hippocampal neuron morphosis. Chin Rem Clin 5 11 (2005) 846-849
59. 5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proc Natl Acad Sci U S A 99 17 (2002) 11452-11457
60. Yang G.D. Muscarinic receptors: a novel therapeutic target for drug addiction. Trends Pharmacol Sci 23 12 (2002) 551
61. 5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice. J Neurosci 22 1 (2002) RC190
62. Blokland A. Acetylcholine: a neurotransmitter for learning and memory?. Brain Res Brain Res Rev 21 3 (1995) 285-300
63. Dalvi R.R., and Peeples A. In vivo effect of toxic alkaloids on drug metabolism. J Pharm Pharmacol 33 1 (1981) 51-53
64. Yoshida M., Yokoo H., Mizoguchi K., Kawahara H., Tsuda A., Nishikawa T., et al. Eating and drinking cause increased dopamine release in the nucleus accumbens and ventral tegmental area in the rat: measurement by in vivo microdialysis. Neurosci Lett 139 1 (1992) 73-76
65. Mark G.P., Rada P., Pothos E., and Hoebel B.G. Effects of feeding and drinking on acetylcholine release in the nucleus accumbens, striatum, and hippocampus of freely behaving rats. J Neurochem 58 6 (1992) 2269-2274